Scarica l'app Stockscreener
21.98
0.92%
0.20
Dopo l'orario di chiusura:
22.42
0.44
+2.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Can Roivant Sciences Ltd. stock double in next 5 yearsMarket Performance Summary & Weekly Stock Breakout Alerts - ulpravda.ru
How Roivant Sciences Ltd. stock reacts to global recession fears2025 Big Picture & Community Supported Trade Ideas - ulpravda.ru
Is Roivant Sciences Ltd. stock positioned for digital transformation2025 Investor Takeaways & Target Return Focused Stock Picks - ulpravda.ru
How Roivant Sciences Ltd. stock performs in rate cut cyclesWeekly Market Outlook & Long Hold Capital Preservation Plans - ulpravda.ru
Aug Big Picture: How Roivant Sciences Ltd. stock reacts to global recession fearsWeekly Earnings Recap & Real-Time Volume Surge Alerts - ulpravda.ru
What Roivant Sciences (ROIV)'s Accelerated Brepocitinib Push Means For Shareholders - simplywall.st
A Look At Roivant Sciences (ROIV) Valuation After Brepocitinib Timeline Acceleration And Profitability Outlook Shift - simplywall.st
Why Roivant Sciences Ltd. stock could be next big winner2026 world cup usa national team third place match top scorers high defensive line odds analysis insights - ulpravda.ru
Leerink Partners reiterates Outperform rating on Roivant Sciences stock By Investing.com - Investing.com Australia
Leerink raises price target as Roivant (ROIV) accelerates drug development pipeline - MSN
Psithera spun out of Roivant with $47.5M and immune, inflammatory focus - BioWorld MedTech
Penn Davis Mcfarland Inc. Buys 170,456 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Pacer Advisors Inc. Makes New Investment in Roivant Sciences Ltd. $ROIV - MarketBeat
Behavioral Patterns of ROIV and Institutional Flows - Stock Traders Daily
Leerink Raises Price Target as Roivant (ROIV) Accelerates Drug Development Pipeline - Insider Monkey
Roivant Sciences Insider Sold Shares Worth $28,902,500, According to a Recent SEC Filing - MarketScreener
Book value per share of Roivant Sciences Ltd. – DUS:87S - TradingView — Track All Markets
Mayukh Sukhatme Sells 1,018,995 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Mayukh Sukhatme Sells 311,873 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Short Interest in Roivant Sciences Ltd. (NASDAQ:ROIV) Drops By 16.2% - MarketBeat
15 Best Stocks Under $25 to Buy Now - Insider Monkey
Insider Selling: Roivant Sciences (NASDAQ:ROIV) CEO Sells 75,000 Shares of Stock - MarketBeat
Richard Pulik Sells 406,731 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Roivant Sciences Executives Engage in Significant Share Sales - TradingView — Track All Markets
Capricorn Fund Managers Ltd Buys New Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Insider Confidence In December 2025's Leading Growth Companies - Yahoo! Finance Canada
Reassessing Roivant Sciences (ROIV) Valuation After Pipeline Progress, NDA Timelines and Genevant Litigation Updates - simplywall.st
Voya Investment Management LLC Grows Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Is Roivant Sciences Ltd stock positioned for digital transformationGap Down & High Conviction Trade Alerts - moha.gov.vn
What margin trends mean for Roivant Sciences Ltd. stockFibonacci Extensions & Fast Profit Trading Tips - bollywoodhelpline.com
Ramaswamy-Backed Ambros Launches with $125M - Orange County Business Journal
Roivant Sciences president Sukhatme sells $619k in shares By Investing.com - Investing.com Australia
Roivant Sciences president Sukhatme sells $619k in shares - Investing.com UK
How Investors May Respond To Roivant Sciences (ROIV) Accelerating Brepocitinib Timelines And Patent Litigation - simplywall.st
H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock - MSN
Why Roivant Sciences Ltd. stock is in analyst buy zone2025 Fundamental Recap & Reliable Entry Point Trade Alerts - Улправда
US Market Recap: What margin trends mean for Roivant Sciences Ltd stockJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - moha.gov.vn
Sell Signal: Will Roivant Sciences Ltd stock maintain momentum in 2025Weekly Stock Report & Pattern Based Trade Signal System - moha.gov.vn
Can Roivant Sciences Ltd. stock maintain operating marginsJuly 2025 Chart Watch & Accurate Buy Signal Notifications - Улправда
How Roivant Sciences Ltd. (87S) stock reacts to fiscal policiesJuly 2025 EndofMonth & Free Expert Verified Stock Movement Alerts - Улправда
Roivant Sciences (NASDAQ:ROIV) Insider Mayukh Sukhatme Sells 26,831 Shares - MarketBeat
Pres Sukhatme Sells 26,831 ($619.5K) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Can Roivant Sciences Ltd. stock outperform in 2025 bull marketMarket Activity Summary & High Conviction Buy Zone Alerts - DonanımHaber
Why Roivant Sciences Ltd. stock remains undervaluedVolume Spike & Consistent Return Strategy Ideas - Bölüm Sonu Canavarı
Will Roivant Sciences Ltd. stock maintain momentum in 2025Weekly Stock Analysis & Long-Term Growth Plans - DonanımHaber
Roivant Sciences Insider Sold Shares Worth $39,065,213, According to a Recent SEC Filing - marketscreener.com
Published on: 2025-12-19 09:31:09 - ulpravda.ru
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):